Companies Begin Subsidizing Color Genomics' Breast, Ovarian Cancer Testing For Employees
Eighteen organizations have agreed to cover at least half the cost of Color Genomics' breast and ovarian cancer risk test for their employees, the diagnostic company announced today.
Earlier this year, the Burlingame, California-based firm began marketing a $250 test that gauges 19 genes, including BRCA1 and BRCA2, for assessing the risk of breast and ovarian cancer. In honor of Breast Cancer Awareness Month, throughout October, Color has dropped the price of the saliva test to $199.
Earlier this year, the Burlingame, California-based firm began marketing a $250 test that gauges 19 genes, including BRCA1 and BRCA2, for assessing the risk of breast and ovarian cancer. In honor of Breast Cancer Awareness Month, throughout October, Color has dropped the price of the saliva test to $199.